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ABSTRACT 
Introduction: Many studies reported that the practice of Naturopathy, especially with 
hydrotherapy treatment, influences in improving pulmonary function. The current 
study was conducted to determine the effect of using Cold Chest Pack for improving 
pulmonary functions. 
Objective: The intended research work aims at assessing the efficacy of Cold Chest 
Pack in improving the Pulmonary functions of Bronchial Asthma patients 
Study Design: Randomized Control Trial. 
Method: A total of 71 study subjects belonging within the age group of 20-44 years, 
participated in the study. The study participants were randomized into intervention 
and control group. The intervention group participants will be given cold chest pack 
for 30 minutes for 25 days (5 days/week for 5 weeks) along with conventional 
medicine. Control group will be only under conventional medicine. After 5 weeks 
again PEFR will be recorded for both groups.  
Result: The study showed significant improvement in the PEFR values of the study 
participants. The pulmonary function observed to be significantly improved with cold 
chest pack among study participants. 
Conclusion: The practice of hydrotherapy mediated Cold Chest Pack facilitates in 
improving the PEFR and strengthening the pulmonary function significantly. 
Keywords: Peak Expiratory Flow Rate, Cold Chest Pack, Pulmonary Function, 
Hydrotherapy 
xi 
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1.0 INTRODUCTION 
The prime objective of the project is to establish the significance and efficacy 
of the medical system involving Naturopathy, over the Conventional Medical System, 
especially with reference to cold compression.  
There is a noticeable increase in health care burden from asthma in several 
areas of the world. There is also a global concern on the change in asthma 
epidemiology and clinical spectrum. There is not only an apparent increase in general 
prevalence in several geographic areas, but also in the number of cases of difficult, 
refractory and fatal (or near fatal) asthma. Moreover, there are complex and 
confounding associations and relationships with infections and infestations, air 
pollution, tobacco smoking and environmental tobacco smoke exposure
1, 2
.  
1.1 Definition of Asthma 
The word asthma originates from an ancient Greek word meaning panting
3
. 
The global strategy for asthma management and prevention guidelines define as a 
chronic inflammatory disorder of the airways associated with increased airway hyper 
responsiveness, recurrent episodes of wheezing, breathlessness, chest tightness and 
coughing particularly at night or early morning. Airway inflammation produces 
airflow limitation through acute broncho-constriction, chronic mucus plug formation 
and airway wall swelling or remodeling
4
. Asthma is a Reversible Obstructive Airway 
Disease (ROAD) coupled with bronchial hyper- responsiveness (BHR) and airway 
inflammation. ASTHMA = ROAD (reversible obstructive airway disease) + BHR 
(bronchial hyper responsiveness). 
2 
 
 
Figure 1.1:  Changes in airway wall, muscle and lumen of Bronchus and Alveoli 
in Bronchial Asthma 
Asthma is a heterogenous disorder that is characterized by variable airflow 
obstruction, airway inflammation and hyper responsiveness, and reversibility either 
spontaneously or as a result of treatment
5
. Chronic inflammation is related with 
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airway hyper responsiveness leading to wheezing, shortness of breath, chest tightness 
and coughing, particularly during night or early in the morning. Asthma is a global 
problem estimated to affect 300 million people around the world
4
.  
Depending on the severity of bronchial asthma in the individual patient, there 
may be phases of partial or total freedom from symptoms, alternating with periods of 
variably severe illness. This fact has been integrated into the definition of bronchial 
asthma, which is now defined as a chronic inflammatory disease of the airways 
characterized by bronchial hyper-reactivity and a variable degree of airway 
obstruction. 
Airway obstruction in bronchial asthma is mainly caused by the following four 
mechanisms: 
 Contraction of bronchial smooth muscle 
 Edema of the airway walls 
 Mucous plugging of the bronchioles 
 Irreversible changes in the lungs ("remodeling"). 
1.2 Manifestations of asthma 
Bronchial asthma
6
 is a medical condition which causes the airway path of the 
lungs to swell and narrow. Due to this swelling, the air path produces excess mucus 
making it hard to breathe, which results in coughing, short breath, and wheezing. The 
disease is chronic and interferes with daily working. 
4 
 
 
 
 
Figure 1.2: Manifestations of Asthma 
1.3 Causes and Risk factors 
 Though the root cause of bronchial asthma is unclear, it occurs largely due to 
environmental or genetic factors. The factors that trigger an asthma reaction are: 
Exposure to substances such as pollen, dust, animal fur, sand, and bacteria, 
which triggers allergic reactions
7
. 
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Figure 1.3: Triggering factors of Asthma 
Other includes, 
 Viral Infection like cold and flu, or pneumonia. 
 Air Pollution, smoke, fumes from vehicles, etc. 
 Stress and anxiety. 
 Physical activity or exercise induced asthma. 
 Medications like aspirin, Ibuprofen, beta-blockers, etc. 
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lung Function 
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Hydro-
Meterological 
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 Acid reflux or gastroesophageal reflux disease (GERD). 
 Perfumes and fragrances. 
 Weather, especially extreme changes in temperature. 
 
Figure 1.4: Factors responsible for Asthma 
Risk factors of asthma can be outlined under personal and environmental 
factors. Heredity, gender and obesity are the main subtitles of personal factors. 
Environmental factors comprise of allergens, infections (especially viruses), 
occupational sensitisers, smoking (active and also passive), air pollution (inner and 
outer) and lifestyle (rural life, diet, consumption of antibiotics etc.).  
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1.4 The Abnormalities of Pulmonary Function in Asthma 
The primary functional disturbance in asthma
8
 is bronchial narrowing or 
obstruction. This may be due to spasm of the bronchial muscles, swelling of the 
bronchial walls or obstruction of the lumen by mucus. Bronchial obstruction makes 
the flow of air in and out of the lungs more difficult. In particular, the time required to 
expel the inspired air is increased. If the expiratory forces are insufficient to expel all 
of the inspired tidal volume then air will be trapped in the lungs and pulmonary 
ventilation will be impaired. This hypoventilation may be associated with hypoxia and 
carbon dioxide retention. Pulmonary emphysema
9 
and other structural damage to the 
lung which sometimes complicates asthma leads to increased insufficiency of 
pulmonary function and may be associated with pulmonary heart disease. 
 
 
Figure 1.5: Normal and Asthmatic Lung and Airway 
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1.5 Pulmonary Function Tests in Asthma 
Pulmonary function
10
 tests can, broadly speaking, be divided into four varieties 
according to whether they test pulmonary ventilation, lung volumes, gas exchange 
(including diffusion across the alveolar walls and ventilation-perfusion relationships), 
or the mechanical properties of the lung.  
1.5.1 Pulmonary Ventilation  
Dynamic measurements of pulmonary ventilation
11
 are convenient and also 
very sensitive indicators of the severity of asthma and need no more elaborate 
apparatus than a recording spirometer. The forced expiratory volume in one second 
(FEV1) is the volume of air expired in one second in a forced expiration after a 
maximum inspiration. It is a measure of the expiratory flow rate and is a simple 
repeatable and sensitive test of expiratory obstruction. The FEV1 is low in asthma and 
is increased by effective broncho-dilators. The vital capacity (VC) is the maximal 
volume of air that can be expired following a maximum inspiration. It is a poor index 
of the severity of asthma since it is not a dynamic (timed) measurement. Thus, given 
enough time, an asthmatic may be able to empty the lungs of air satisfactorily so that 
the VC may be little impaired in asthma and influenced little by effective 
bronchodilators
12
. The ratio is a valuable index of expiratory VC obstruction. It is 
normally 80 per cent or more, but is low where asthmatic bronchial obstruction or air 
trapping due to emphysema is present. Patients with uncomplicated asthma attain a 
normal ratio when fully recovered, but where asthma is complicated by chronic 
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emphysema the ratio remains low in spite of effective treatment of asthmatic bronchial 
obstruction
13
. 
CITRON: Pulmonary Function in Bronchial Asthma 
 
 
Figure 1.6: Diagram of Pulmonary Ventilation and Volumes 
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The maximum breathing capacity (MBC) is the maximal volume of air that can 
be breathed per minute. This is reduced in asthma. It is a more difficult and exhausting 
test for the patient and needs more co-operation than the FEV test, and in any case its 
value can be reliably predicted by multiplying the value of the FEV, in litres by 35
14
. 
Progressive elevation of respiratory level at the beginning of inspiration in the MBC 
spirogram tracing to hyperinflation levels is found when air trapping occurs in asthma 
or emphysema. The peak expiratory flow rate is reduced in asthma and may be simply 
measured by a specially designed peak flow meter. 
1.5.2 The Mechanical Properties of the Lung 
Measurements of intrathoracic pressures
15
 by means of intraoesophageal 
pressure recorders show that during asthma respiratory pressure swings are much 
increased, becoming very low on inspiration and high on expiration.  
The work of breathing, which is measured by the product of the pressure 
change and the volume change, is greatly increased so causing the patient the 
sensation of dyspnoea and increasing the oxygen demands of the body.  
Lung compliance defines lung stiffness or elasticity and is expressed as 
volume change per unit of pressure change. Increased lung stiffness, that is low 
compliance, is usually found in asthma
16
.  
Lung resistance, which is expressed as pressure change per unit of gas flow, is 
increased in asthma in association with the bronchial obstruction. 
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1.6 Diagnosing Bronchial Asthma 
Because asthma symptoms17 don't always happen during your doctor's 
appointment, it's important for you to describe yours, or your child's, asthma signs and 
symptoms to your health care provider. You might also notice when the symptoms 
occur such as during exercise, with a cold, or after smelling smoke.  
Asthma tests
18
 may include: 
 Spirometry: A lung function test to measure breathing capacity and how well you 
breathe. You will breathe into a device called a spirometer. 
 Peak Expiratory Flow (PEF): Using a device called a peak flow meter, you 
forcefully exhale into the tube to measure the force of air you can expend out of 
your lungs. Peak flow monitoring can allow you to monitor how well your asthma 
is doing at home. 
 Chest X-ray: Your doctor may do a chest X-ray to rule out any other diseases that 
may be causing similar symptoms. 
1.7 Naturopathy 
Naturopathy is a science of disease elimination without drugs. It is based on the 
principle of cooperation with the natural laws of life which are forever working 
within, as well as outside the body and it makes use of only the natural elements like 
water, air, light, heat, food, etc., for the purpose of curing disease
19
. 
Naturopathy can be defined as a drugless, non-invasive, rational and evidence-
based system of medicine imparting treatments with natural elements based on the 
12 
 
theories of vitality, toxemia and the self-healing capacity of the body and the 
principles of healthy living. Naturopathic life- style is a form of holistic mind-body 
medicine, developed thousands of years ago, is simple and can be practiced by all
20
. 
1.8 Hydrotherapy in treatment of Bronchial Asthma 
Hydrotherapy treatment
21
 is a part of naturopathy process that involves using 
water as an effective treatment as it promotes healing. It serves as a treatment of various 
disorders via utilizing different states of waters. Their application using all states of water 
has been in practice since age-old days. Hydrothermal therapy additionally uses 
temperature effects, as in hot & cold baths, saunas, wraps, etc., and in all its forms-solid, 
fluid, vapour, ice and steam, internally and externally. Water is without doubt the most 
ancient of all remedial agents for disease. Healing
22
 could be achieved via steam 
inhalation, warm/ cold compresses nasal irrigation. Such techniques tend to loosen the 
secretion of nasal airway as well as cleanse the mucosal linings of the nasal passage. 
Besides they facilitate in improving the breathing and drainage as well. In case of 
aromatic steam involves with numerous herbal remedies which in turn soothes the 
inflamed nasal mucosa and sinus membrane. However for the present study, we 
incorporate cold chest pack as an effective hydrotherapy mediated approach for treating 
bronchial asthma. 
1.8.1 Cold chest pack 
It is a part of hydrotherapy treatment
23
 facilitating in an increased peak 
expiratory flow rate with exhibiting an immediate effect on bronchial asthma patients. 
Temperature of the chest‟s cavity is diminished considerably within ten minutes of 
13 
 
application of the thoracic compress. Chest‟s blood-vessels are made to instantly 
contract upon its contact with where the cold compress has been made. And on 
reaction phase (after ten minutes) there will be dilation of bronchial vessels and tract 
which enhances free expiration where asthmatic patients getting trouble. The tidal air 
also increased more than 1/3
rd
 in volume.  
The immediate effect of a cold chest pack application has been related to 
different factors, viz, (i) Circulatory effects, since the application is believed to cause 
vasoconstriction of blood vessels in the skin over the chest and (ii) the cold 
stimulation may also increase overall sympathetic tone, hence bringing about 
bronchodilation
24
. This is especially important as it is generally understood that there 
is sympathetic beta receptor hyposensitivity in bronchial asthma, along with a 
adrenoreceptor hypersensitivity and parasympathetic hypersensitivity
25
. 
1.9 RATIONALE: 
Cold chest pack is being widely used as a therapy in naturopathic system of medicine. 
The previous study on this was done without control group and done along with other 
naturopathy, yoga and acupuncture treatments. So the rationale is to observe the 
changes in PEFR among asthmatic patients with cold chest pack with a control group 
under conventional medicine. 
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2.0 AIMS AND OBJECTIVES 
 
Aim: 
To evaluate the effect of Cold Chest pack on pulmonary changes in patients with 
Bronchial asthma. 
Objectives:  
To observe the changes in PEFR while applying Cold chest pack in Bronchial 
asthmatic patients. 
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3.0 REVIEW OF LITERATURE 
3.1 BRONCHIAL ASTHMA 
Asthma is a chronic inflammatory disease characterized by symptoms 
(dyspnoea wheezing, chest tightness and coughing), airway inflammation, reversible 
airflow obstruction, bronchoconstriction, airway hyper reactivity (AHR), influx and 
activation of inflammatory cells, plasma exudation, increased mucus production and 
airway remodeling
26
. This disease triggered by mast cells activated via 
immunoglobulin E (IgE)-mediated allergic challenge.  
Studies of allergic lung inflammation have identified a number of effector cells 
and their mediators. It involves the activation of many cells like mast cells, 
macrophages/monocytes, eosinophils, T-helper type-2 lymphocytes (Th2), dendritic 
cells, basophils, neutrophils and platelets (inflammatory) and epithelial cells, smooth 
muscle cells, endothelial cells and fibroblasts (structural) are all capable of 
synthesizing and releasing inflammatory mediators
27
. Activation of these cells by 
allergen leads to release of inflammatory mediators like cytokines, prostaglandins 
(PGs), leukotrienes (LTs), interleukins (ILs) and thromboxane (TXA2)
28
. Several 
previous studies have emphasized the role of these mediators in the pathogenesis of 
allergic inflammation and asthma. In addition, there is increasing clinical and 
experimental evidences suggest that excess production of reactive oxygen species and 
defective endogenous antioxidant defense mechanisms may be present in asthma
29, 30
. 
It is a multifactorial disease process associated with genetic, allergic, environmental, 
infectious, emotional, and nutritional components. 
16 
 
 
 
Figure 3.1: Illustrated manifestation of Asthmatic Airway 
 
3.2 PREVELANCE OF BRONCHIAL ASTHMA  
Millions of people have allergic diseases. It is estimated that 20% of all 
Americans have either rhinitis, asthma, or other allergic diseases
31
. Bronchial asthma 
is one of the most common illnesses in the western world. Asthma affects 
approximately 8% of the world's population
32
. In United States the prevalence is 71%. 
17 
 
Approximately 5,000 people die each year due to asthma. Across racial and 
socioeconomic groups, the death rate from asthma mirrors the incidence, with 
African-Americans having the highest mortality from this disease. The death rates for 
asthma are higher in the inner city and in lower socioeconomic groups.  
The exact cause of this difference might be due to genetic, socioeconomic, 
and/or access to the health care issues. Direct costs (doctors‟ visits, hospitalization, 
drugs, etc.) and indirect costs (work and school absenteeism, etc.) of asthma vary, 
depending on the reference, but are estimated to be approximately $6 billion per 
year
33
. The incidence of asthma and the morbidity and mortality caused by asthma 
have increased during the last 30 years in developed countries despite the advent of 
new drug treatments and increasing awareness of the need for better disease 
management
34
. Prevalence varies from region to region depending upon the definition 
used for diagnosis of asthma
35
. 
In 2012, approximately 8% or 18.7 million US adults were diagnosed with 
asthma
36
. The prevalence of intermittent asthma ranged from 23.6% in Alabama to 
43.5% in Utah between 2006 and 2010; no specific geographic pattern was identified. 
The prevalence of asthma is higher among younger adults (18–24 years of age). The 
prevalence of asthma was 10.3% in the 18–24 year age group, 8.7% in the 25–34 year 
age group, 8.1% in the 35–44 year age group, 8.5% in the 45–54 year age group, 9.4% 
in the 55–64 year age group, and 8.1% in the 65 and older age group in 201037.  
A cross-sectional survey
38
 demonstrated that the prevalence of childhood 
asthma in the cities of Beijing, Chongqing, and Guangzhou was 3.15%, 7.45%, and 
2.09%, pointing toward rising prevalence. Behavioral and environmental factors also 
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play a role. The genetics involved in the eventual development of asthma is complex 
and incompletely understood
39
. 
Diagnosed asthma in adults is generally reported as 2.7 to 4.0% in most 
European countries, 12.0% in England
40 
and 9 5 to 17 9% in Australia
41
. The overall 
burden of asthma in India is estimated at more than 15 million patients
42
. 
 
 
Figure 3.2: Global Asthma Report and its prevalence 
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The following illustration represents the prevalence of Bronchial asthma in India 
comparing 1990 and 2016 
 
Figure 3.3: Prevalence of Bronchial Asthma in India (1990 and 2016) 
3.3 ETIOLOGY OF BRONCHIAL ASTHMA 
Increasing evidence from case control surveys, population studies and allergen 
avoidance studies suggests inhalant allergy plays an important role in the etiology of 
asthma
43
. Although an association between inhalant allergy and asthma has been 
recognized for over 100 years, in many cases it has been difficult to demonstrate cause 
and effect. This is because in part some asthmatic patients are non-allergic, and even 
in allergic patients many other factors are known to trigger asthma attacks
44
.  
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Figure 3.4: Mechanism of Asthmatic attacks by triggering factors 
Exposure to certain stimuli initiates inflammation and structural changes in 
airway hyper responsiveness and variable airflow obstruction, which in turn cause 
most asthma symptoms. There are large numbers of such stimuli; the more important 
includes environmental, chemical exposure, occupational sensitizing agents, 
respiratory viral infections and nonspecific irritant inhalation
45
. 
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Table 3.1: List of agents responsible as triggers in asthma (Chauhan et ah, 1996) 
 
LIST OF AGENTS EVENTS TRIGGERING ASTHMA 
ACUTE AIRWAY Bacterial: H influenza, S. pneumonia, M Cattarhalis 
INFECTION Viral Rhinoviruses, Picorna viruses, Respiratory 
syncytial virus (RSV), influenza A, B, Coronaviruses, 
Atypical‟ C Pneumonia 
ALLERGENS Air born pollens (grass, trees, weeds), house-dust 
mites (Dermatophagoides pteronyssinus), animal 
dander, cockroaches and fungal spores 
ENVIRONMENT Cold air, fog, ozone, sulfur dioxide, nitrogen, tobacco 
smoke and wood smoke 
EMOTIONS Anxiety, stress, laughter 
EXERCISE Particularly in a cold, dry climate 
DRUGS/PRESERVATIVES Aspirin, NSAIDs, sulfites, benzalkonium chloride, p-
blockers 
OCCUPATIONAL 
STIMULI 
Bakers (flour dust), farmers (hay mold); spice and 
enzyme workers, printers (arabic gum); chemical 
workers (azodyes, anthraquinone, ethylenediamme, 
toluene, diisocyanates, PVC); Q plastics, rubber and 
wood workers (formaldehyde, western cedar, 
dimethylethanolamine, anhydrides 
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3.4 RISK FACTORS OF ASTHMA 
 Exposure to tobacco smoke  
  Previous allergic reactions, including skin reactions, food allergies or hay 
fever (allergic rhinitis)  
 A family history of asthma, allergic rhinitis, hives or eczema  
 Living in an urban area with increased exposure to air pollution  
 Low birth weight, Obesity  
 A chronic runny or stuffy nose (rhinitis)  
 Severe lower respiratory tract infection, such as pneumonia  
 Inflamed sinuses (sinusitis) 
 Heartburn (gastroesophageal reflux disease, or GERD)  
 Being a male46. 
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Figure 3.5: Risk Factors in Asthma 
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3.5 SYMPTOMS OF ASTHMA 
• Shortness of breath 
• Rapid breathing 
• Spasmodic  cough 
• Severe wheezing 
• Anxiousness 
• Difficulty in talking 
• chocking sensation 
• Tightness in neck muscles 
• Blue lips and / fingernails 
• Tightness in chest 
• Pale and sweaty face 
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 Figure 3.6: Symptoms of Asthmatic Attack 
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3.6 MECHANISM AND PATHOLOGICAL COMPLICATIONS BEHIND 
ASTHMA 
The respiratory system
47
 plays a major role in exchanging gases in the body. It 
brings oxygen to the lungs and disposes of carbon dioxide. With every breath, air 
enters the body via the mouth or nose and moves down towards the lungs through the 
airway. The airway leads to the chest, where it splits into two – the bronchiole. Each 
of the bronchiole splits into smaller tubes until they reach the nodes in the lungs. If the 
bronchioles are blocked, less oxygen reaches the lungs, resulting in respiratory 
problems. The lining of the bronchiole has a number of glands which secrete mucus. 
During an asthma attack the bronchiole contracts (bronchospasm) while the lining 
expands and fluids build up, further constricting the airway. In many cases, the asthma 
attack occurs after exposure to stimuli. These stimuli are called allergens. Sometimes, 
the attack is the result of exercise or other agents that are not directly connected to an 
allergic reaction. Viral infections also cause asthma attacks. 
 
Figure 3.7: Illustration of Bronchial Asthma 
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Figure 3.8: Pathology of Asthma 
  When a person with asthma suffers from an asthma attack
48
, the attack happens 
in two stages. During the first stage, the muscles surrounding the airways contract and 
mast 34 cells are released. Afterwards, the second stage of inflammation begins. A 
large number of inflamed cells build up in the airway and release substances which 
worsen the constriction of the surrounding muscle and cause a build-up of fluid in the 
lining of the bronchiole. The inflammation worsens over a period of time and if left 
untreated, can become chronic and cause irreparable damage to the airways. Asthma is 
an overreaction to various stimuli. This overreaction can happen extremely quickly. 
The asthma attack causes three reactions: constriction of the airways, thickening of the 
inner lining and secretion of sputum into the airways. Together, these three reactions 
block the airways, making it difficult to breathe and it results in shortness of breath. 
Children‟s airways are smaller than adults, which makes their asthma attacks more 
severe
49
. 
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Figure 3.9: Mechanism behind Asthma 
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The pathophysiologic basis of asthma is not clearly understood. It appears to 
have complex, multifactorial etiology which results from an interplay of many 
hereditary factors and more number of environmental factors. Bronchial biopsies from 
patients with even mild asthma have marked evidence of chronic inflammation, and 
cytokines and other mediators of inflammation are well found in bronchial washings 
from asthma patients. Some families are more prone to development of allergies, and 
there is a well-known co-relation between allergies and asthma.  
This suggests a genetic predisposition, but it appears that a number of genes are 
involved in this mechanism. Allergic reactions are mediated by antibodies of IgE 
class. People who are prone to IgE-mediated allergic reactions are said to be "atopic” 
meaning, they have a genetic predisposition to make IgE antibodies in response to 
certain allergens. While allergic reactions are mediated by IgE antibodies, T and B 
lymphocytes play an important role in production of IgE. There are two different types 
of T helper cells (Th lymphocytes) designated Th1 and Th2.  
Th1 cells tend to promote cell-mediated immune responses by producing 
cytokines like interferon-gamma, interleukin-2 (IL-2), and TNF-β. In contrast, Th2 
cells promote the production of IgE antibodies by producing IL-4 and IL-13, which 
are interleukins that act on B lymphocytes (B cells) to promote the production of IgE 
antibodies to a specific antigen. People who are prone to develop allergies, i.e., atopic 
people, believed to have a higher ratio of Th2/Th1 cells, and this is believed to be an 
important factor in the tendency to produce allergy-mediating IgE antibodies. These 
observations are evidently relevant to asthma, since biopsies of the bronchial mucosa 
of patients with asthma have surplus of activated Th2 cells. These observations 
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indicate that an imbalance in Th2/Th1 plays an important role in the development of 
allergies and, specifically, of asthma. 
 
 
Figure 3.10: Mechanism and Pathophysiology behind Asthma 
 
Cold chest pack
50
 along with hot foot and arm bath for bronchial asthma is 
clinically used in naturopathy to relieve pulmonary congestion, decrease pulmonary 
mucous membrane irritation and increase the depth of respiration. Cold chest pack 
increased peak expiratory flow rate as an immediate effect in bronchial asthma 
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patients. Cold chest pack along with hot foot and arm bath in bronchial asthma 
patients is believed to reduce pulmonary congestion, decrease pulmonary mucous 
membrane irritation and increase depth of respiration. 
Naturopathy along with other treatment modalities uses cold chest pack as the 
first line of treatment in the management of various disorders. The chest pack is used 
in pulmonary congestion, pulmonary tuberculosis, chronic bronchitis, chronic 
pneumonia, chronic pleuritis, pulmonary hemorrhage and threatened cardiac failure 
51
.  
Quinlan
52
 et al., (2002) study showed spa therapy improved ventilator function in 
steroid dependent intractable asthma. Sathyaprabha
53 
et al., (2001) made a study on 
naturopathic intervention (included massage, hydrotherapy, colour therapy, fasting 
and diet therapy, mud and yoga therapy) in bronchial asthma patients showed 
significant improvement PEFR, vital capacity, forced vital capacity, forced expiratory 
volume1, FEV/FEC%, Maximum voluntary ventilation and absolute eosinophil count.  
Though cold chest pack has been extensively used in clinical scenario both for 
rejuvenation as well as therapy, its underlying mechanisms are less understood. There 
are no previous studies on the effect of cold chest pack on heart rate variability 
specifically as such. It is essential to understand the underlying mechanisms of cold 
chest pack on autonomic nervous system before applying them as therapeutic agents. 
3.7 ASTHMA SUBTYPES  
Asthma is triggered and aggravated by many different sources. Subtypes of the 
condition can be described demographically by age of onset, type and place of 
exposure, and in terms of the pathophysiology of the underlying inflammation.  
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Asthma has been classified according to age (childhood-onset and adult onset 
asthma). Childhood-onset asthma begins during childhood with a peak prevalence of 
10% among children 5–9 years of age37. The “allergic triad” includes asthma, atopic 
dermatitis, and allergic rhinitis, and there seems to be some progression from atopic 
dermatitis and food allergy during infancy to asthma and/or allergic rhinitis during 
childhood
38
. Approximately 58% of all children with asthma are expected to have 
complete resolution of symptoms by adulthood, and 11% will continue to have 
infrequent episodic asthma
39
. Male gender was a significant predictor of asthma 
remission
54
. Adult-onset asthma refers to persons older than 20 years of age. Asthma 
diagnosed among young adults is associated with cold-air bronchial hyper-
responsiveness at 6 years of age, late-onset and persistent wheezing by 6 years of age, 
and female gender
54
. 
 
Figure 3.11: Subtype classification based on age of onset 
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Asthma may also be classified based on the location of the exposure. Work-
related asthma (WRA) includes work-exacerbated asthma (pre-existing or concurrent 
asthma worsened by factors related to the workplace environment) and occupational 
asthma (new-onset asthma attributed to the workplace environment) 
55
. The route of 
inflammatory response also defines asthma. Allergic asthma is mediated by 
immunoglobulin E (IgE) reactions to airborne allergens. Common IgE-mediated 
allergens have been identified from dust mites, pet dander, cockroaches, molds, and 
grass pollens
56
. Symptoms usually begin before the 20th birthday and are usually not 
severe and do not progress; however, heavy exposure can cause acute severe or even 
fatal reactions
57
. 
 
Figure 3.12: Subtype classification based on location of exposure 
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Intrinsic or non-allergic asthma is defined as that which does not involve an 
identified IgE response
58
. This type is more common in middle-aged and older adults. 
Compared with allergic asthma, intrinsic asthma is more persistent, and it is more 
likely to progress in severity and to become irreversible Irritant asthma is caused by a 
non-corrosive chemical that directly causes inflammation of both the upper and lower 
respiratory epithelium
59
. 
 
Figure 3.13: Subtype classification based on response to inflammation 
Irritants include a wide variety of chemicals that are found in the home, 
workplace, and outdoor environment. Examples of irritants include solvents found in 
paints and glues, chlorine, bleach, and ammonia in household cleaners, hydrochloric 
and sulfuric acid, floor sealants, formaldehyde, capsaicin found in hot peppers, and 
metal-working fluids
59
. Common outdoor air pollutants are byproducts of fuel 
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combustion and include ozone, fine particulate matter, nitrogen dioxide, and sulfur 
dioxide
60
. 
Asthma can also be exacerbated by other extrinsic physical factors. Exercise-
induced bronchoconstriction (EIB) is defined as the transient narrowing of the lower 
airways that occurs after vigorous exercise. EIB may occur in persons with or without 
the diagnosis of chronic asthma. The diagnosis of EIB usually requires a 10%–15% 
decrease in post-exercise forced expiratory volume in 1 s (FEV1) (pulmonary function 
test) compared to pre-exercise value
61
. 
 
Figure 3.14: Exercise-induced bronchoconstriction (EIB) 
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3.8 CONTROL OF ENVIRONMENTAL TRIGGERS  
Patients with asthma symptoms should be assessed for triggers that affect their 
condition. Skin testing or serum analysis of the IgE response to panels of common 
allergens can help to identify specific causes. If a single source of allergen reactivity is 
identified from testing, then one should consider allergen immunotherapy
62
. Potential 
environmental triggers to asthma are identified with the use of questionnaires.  
A review of the literature has not identified any specific environmental 
questionnaires available that have been validated in controlled studies. Home 
intervention programs are focused on instructing patients how to reduce exposure to 
indoor allergens and respiratory irritants
62
. Home investigators can also be trained to 
identify sources of triggers and implement low cost ways to decrease exposure. 
Evidence-Based Review reducing home allergen content from house dust mites, 
cockroaches, animal dander, and mold have been developed
56
.  
Other common home irritants include exposure to paint, glue solvents, 
household cleaners, pesticides, and tobacco smoke. Use of a gas stove with poor 
ventilation and wood burning stoves can also be a large contributor of particulate 
irritants in home
56
.  
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The following Figure illustrates the common environmental triggers 
responsible for bronchial asthma. 
 
Figure 3.15: Common Environmental Triggers responsible for Bronchial Asthma 
3.9 ALTERNATIVE TREATMENT OPTIONS FOR TREATING ASTHMA 
Yoga 
One of the fundamental philosophical tenets of Yoga
63
, which means "union" 
(of body and spirit) and is an ancient Indian meditative exercise technique, is that the 
breath is the most important bodily function that needs to be controlled. The Sanskrit 
word for breath is "prana" which also means life force or spirit. Thus, control of the 
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breath is crucial for optimal health and wellbeing, and a good place to start when life 
or health is out of balance. Breathing exercises are extremely helpful for asthmatics 
because they strengthen respiratory muscles, eliminate inefficient use of accessory 
muscles of respiration (such as abdominal or neck muscles), replace forceful 
breathing, which compresses airways, with relaxed breathing it can reduce 
hyperventilation, by increasing expiration it can reduce the sensation of 
breathlessness, by increasing the functioning of the diaphragm it can enhance clearing 
of airways and it can give the confidence to withstand breathlessness. 
To help control an acute asthma attack, the patient should be asked to sit 
leaning forward with their head on their arms that should rest on a table. Alternatively, 
the patient can try lying semi-prone, with arms and legs slightly bent and relaxed, 
body and limbs well supported by pillows. 
Light Therapy 
Light therapy stated by Dr. Richard Brouse, a chiropractic physician, 
biochemist, certified clinical nutritionist, teacher, and author, says, 'The gentle heat of 
far-infrared helps to detoxify the body, promotes relaxation, and improves 
circulation
64
. It can also help ease the pain and symptoms of problems such as 
arthritis, allergies, asthma, injuries, and diabetes. In almost every instance, it seems to 
reduce pain and speed the healing process. Again, thousands of people have reported 
wonderful benefits from the use of the Hot house and many after using it the very first 
time. Trying to describe what this complete therapy feels like is comparable to trying 
to describe your most wonderful vacation you were on to your best friend. Words can't 
describe it, and you need to experience it. 
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Siddha medicine  
The leaves of the Justicia adhatoda
65
 plant contain the alkaloid, vasicine 
(C11H12N2O), which is responsible for low-level, persistent bronchodilatation, and 
an essential oil which is chiefly responsible for expectorant action. The leaves and 
roots contain other alkaloids vasicinone, vasicinolone, and vasicol which may 
contribute to the bronchodilatory effect through anticholinergic action on the vagal 
innervations of the bronchi. The bronchodilation effect is considerably increased after 
atropine administration. Studies have also shown Vasa to be effective in the treatment 
of amlapitta (dyspepsia) and pyorrhea. In vitro growth of several strains of 
Mycoplasma tuberculosis was inhibited by the essential oil at concentrations in the 
range of 220 g/mL. There has also been a report of thrombopoetic (platelet-increasing) 
activity with vasicine. Traditional Uses: The juice expressed from the leaves and the 
decoction of the leaves and roots are useful in asthma, bronchitis, and other chronic 
coughs. Dried leaves are used in dhoomapana (smoking) in the treatment of bronchial 
asthma. The leaf decoction is an excellent expectorant when decocted with punarnava 
(Boerhaavia diffusa) and then combined with ginger juice and black pepper. Another 
effective preparation for the treatment of asthma is the decoction of vasa, guduchi 
(Tinospora cordifolia), and kantakari (Solanum surratense) mixed with honey. Vasa 
have also been used to treat skin conditions by combining it with triphala and using 
the decoction both internally and externally. Vasa is also indicated in the treatment of 
internal hemorrhage, and is used for this indication as a decoction with haritaki, made 
into a ghrita, or taken alone as the leaf juice. 
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Homeopathy 
Homeopathy
66
, major tenet of homeopathy is the law of similar or like cures 
like (i.e., a substance can cure in a patient the same set of symptoms it can induce in a 
healthy individual).  A plant, mineral, or other product is chosen on the basis that it 
would, if given to a healthy volunteer, cause the presenting symptoms of the patient. 
When given in a much diluted form, the chosen homeopathic remedy should alleviate 
these symptoms. Currently, there are over 2000 substances known as remedies in the 
homeopathic Materia Medica. For example, a homeopathic preparation derived from 
cockroaches may be used to treat a form of asthma characterized by suffocation with 
an accumulation of mucus. Another manifestation of asthma might be treated with a 
different preparation. Choosing remedies based on the symptoms rather than the 
disease itself is an integral part of the holistic approach to treatment by homeopathic 
practitioners. As the remedy in its pure form would likely have some degree of 
toxicity, it is diluted and shaken (succussed) in a 1:10 (X or D for decimal) or 1:100 
(C for centesimal) dilution in a water-alcohol solution. The higher the dilution is, the 
more potent is the medicine. Insoluble substances are pulverized and formed into 
pellets with sucrose and/or lactose. Highly diluted preparations are greater than 
Avogadro‟s number and no longer contain the original molecule. The precise 
mechanism of action of homeopathic medicines on biological symptoms is still 
unexplained. For many, the lack of a scientific explanation for homeopathic 
treatments raises questions about its legitimacy. Some believe that complex 
interactions occur during dilutions that impart a memory of the original substance to 
the water molecule. 
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Massage Therapy 
 
Figure 3.16: Massage Therapy 
There are many different types of massage
67
 as they all have one aspect in 
common, They are a holistic, alternative treatment. They bring about an effect on all 
the systems of the body - digestive, detoxification, respiratory, circulatory, lymphatic, 
endocrine, and nervous systems. It is thought that many of today‟s health problems 
arise from stress. However, most people underestimate the effects of a poor diet which 
leaves the body less able to cope with stress. Stress upsets the delicate balance and 
homeostasis of all bodily functions; re-establishing this balance requires a holistic 
approach. Regular massages can be an effective way of calming the whole system, 
which can be enhanced with certain essential oils added to the massage oil or cream. 
Hot Stone Massage Therapy has been used for centuries to relax and treat breathing 
problems. Ancient Ayurvedic therapy with hot river bed stones melts away stress and 
tension and draws out impurities from the body. Several studies show positive effects 
when parents massage their asthmatic children; there is less anxiety and a reduction in 
the stress. 
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3.10 HYDROTHERAPY APPROACHES FOR BRONCHIAL ASTHMA 
Hydrotherapy
68
 is the use of water for recuperative and healing purposes. 
Hydrotherapy treatment is largely considered to be the oldest form of medical 
treatment known to man. Hydrotherapy tubs and other items of hydrotherapy 
equipment are still used in modern times for a vast range of therapeutic measures. 
Along with treating diseases and improving wound healing, circulation, relaxation, 
digestion, and the immune system, hydrotherapy has been proven to be beneficial for 
people with acne, anxiety, arthritis, asthma, back pain, burns, chronic fatigue 
syndrome, constipation, depression, and varicose veins etc. The reviewer suggests that 
the application of water to treat disease has been used throughout history. It is known 
that Hippocrates (460-375 BC) used hot and cold water in the treatment of multiple 
disease states 
Hydrotherapy is the external or internal use of water in any of its forms (water, 
ice, steam) for health promotion or treatment of various diseases with various 
temperatures, pressure, duration, and site. It is one of the naturopathic treatment 
modality used widely in ancient cultures including India, Egypt, China, etc
69
. 
Superficial cold application may cause physiologic reactions such as decrease 
in local metabolic function, local edema, nerve conduction velocity (NCV), muscle 
spasm, and increase in local anesthetic effects. 
At present, hydrotherapy is applied
70
 to treat a myriad of diseases including 
musculoskeletal problems. The majority of the evidence on the effectiveness of 
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hydrotherapy to treat the described disease states and conditions comes from small 
case series/reports and subsequent low level evidence 
The higher level evidence that was reviewed does not suggest hydrotherapy is 
effective in treating osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, 
chronic low back pain, and fibromyalgia or pressure ulcers. There were two papers 
that did suggest that post ACL reconstructive surgery patients may have better 
outcomes than those undertaking land-based exercises alone. 
The application of hydrotherapy is not always without risk. There are reports in 
the literature regarding legionella infections, burn, folliculitis and hypersensitivity 
pneumonitis which were directly related to the hydrotherapy. 
Also the major factors affecting O2 transport during immersion at the time of 
hydrotherapy are temperature and hydrostatic pressure. O2 transport was improved 
above neutral temperature, because of increase in cardiac output resulting from the 
combined actions of hydrostatic counter pressure and body heating. Below neutral 
temperature, O2 transport is altered. At any of the temperatures tested, the pulmonary 
tissue volume and arterial blood gases were not significantly affected. 
Significant decrease in vital capacity (VC) with bath temperature was observed 
(i.e., VC at 40°C >34°C >25°C). Significant increase in tidal volume (VT) in cold or 
hot water compared with thermo neutral water (i.e., VT 40°C >34°C< 25°C). 
Alterations in respiratory muscles functioning might produce variations of the 
pulmonary volumes as a function of water temperature. 
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Asthma is a common condition in which inflammation and narrowing of the air 
conducting tubes may cause intermittent symptoms, possibly limiting activities of 
daily life. Some adults believe that exercise could trigger an asthma attack. However, 
research has shown that the adults who exercise may have less chance of having an 
asthma attack, and taking exercise in water may be more beneficial than taking 
exercise on land. In this review, we aimed to evaluate the effect and safety of water-
based exercise for adults with asthma. 
 
 
Figure 3.17: General Hydrotherapy mediated approach involving water exercise 
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3.11 EFFECT OF COLD CHEST PACK ON PULMONARY FUNCTIONS OF 
PATIENTS WITH BRONCHIAL ASTHMA  
The reversible bronchoconstriction which is characteristic in PEFR, VC, FVC, 
FEV1, FEV/FEC%, MVV (Maximum Voluntary Ventilation) and absolute eosinophil 
count. The changes in   diet
71
, yoga practices
72
 and to other patients reported a feeling 
of well-being, freshness and non-pharmacological externally applied treatments
73
. 
Hence it was concluded that earliest study on yoga suggested that Transcendental 
Meditation, Naturopathy and yoga helps in inducing positive health, was a useful 
adjunct in treating bronchial asthma. A later alleviating the symptoms of disease by 
acting at physical controlled trial with fifty three patients each in yoga and control and 
mental levels. A cold chest pack which is used as a treatment of choice in flow rate and 
decreased weekly attacks of asthma following two weeks of yoga
74
.  
Singh V
75
 et al (1990) evaluated the effect of a single yoga technique (kunjal) 
and showed definite subjective and objective improvements during the week they 
practiced yoga well as improved symptoms after three weeks. Apart from yoga, several 
non-pharmacological treatments have been shown to be beneficial in the treatment of 
bronchial asthma. The changes in ventilatory function were examined in 37 patients 
with steroid-dependent intractable asthma (SDIA) following spa therapy
73
.  
There were significant improvements in Forced Vital Capacity (FVC), Peak 
Expiratory Flow Rate (PEFR), which suggested that the spa therapy improves the 
condition of small airways disorder in patients with SDIA. Sathyaprabha
53 
et al., 
(2001) evaluated the usefulness of Naturopathy intervention (a combination 
treatments including massage, hydrotherapy, color therapy, fasting and diet therapy, 
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mud application and yoga therapy) in bronchial asthma patients. The results suggested 
that there was a significant improvement in PEFR, VC, FVC, FEV1, FEV/FEC%, 
MVV (Maximum Voluntary Ventilation) and absolute eosinophil count. The patients 
reported a feeling of well-being, freshness and comfortable breathing. Hence it was 
concluded that Naturopathy and yoga helps in inducing positive health, alleviating the 
symptoms of disease by acting at physical and mental levels. 
A cold chest pack which is used as a treatment of choice in naturopathy along with 
hot foot and arm bath for bronchial asthma is believed to reduce pulmonary 
congestion, decrease pulmonary mucus membrane irritation and increase the depth of 
respiration
76
. Since there are no studies conducted to evaluated the effects of a cold chest 
pack in isolation on pulmonary functions in bronchial asthma patients, the present 
study was conducted to evaluate the immediate effect of a cold chest pack on the Peak 
Expiratory Flow Rate (PEFR) and whether the immediate effect would change after 21 
days of treatment with other natural remedies and yogic practices in bronchial asthma 
patients. 
The immediate effect of a cold chest pack application has been related to 
different factors, viz, (i) Circulatory effects, since the application is believed to cause 
vasoconstriction of blood vessels in the skin over the chest and (ii) the cold 
stimulation may also increase overall sympathetic tone, hence bringing about 
bronchodilation
24
. This is especially important as it is generally understood that there 
is sympathetic beta receptor hyposensitivity in bronchial asthma, along with a 
adrenoreceptor hypersensitivity and parasympathetic hypersensitivity
25
. 
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Crapo (1994)
77
 had discussed the guidelines for interpretation of pulmonary 
function tests and suggested that such interpretations depend on the equipment used 
and patient‟s performance. Nihlén78 et al (1999) had explained the need for pulmonary 
function analysis for three different sets of smoking adults. The author has discussed 
the clinical importance of lung function analysis for detecting the pulmonary 
emphysema. 
Feyrouz
79
 et al (2003) had described how PFTs are used to identify the patterns 
and severities of abnormality. The authors have analyzed pulmonary function test with 
some typical examples and concluded that interpretation of PFT has to be towards 
recognizing the pattern of 11 physiological impairment. Blieden
80
 et al (2004) had 
statistically explained the lung function during exercise. It is shown that obtaining 
useful information from pulmonary function tests requires both adequate equipment 
and reproducible performance. A guideline for mechanical lung function measurement 
was suggested by Miller
81 
et al (2005). Lung function measures have been investigated 
in relation to traffic indices such as proximity to main roads or modeled traffic related 
pollutants, but again findings in adults are inconclusive and evidence of longitudinal 
effects lacking
82
. 
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4.0 MATERIALS AND METHODOLOGY: 
 
The methodology involved in the following research is described in detail in 
the above chapter.  
4.1 STUDY DESIGN: 
 The study employed Randomized Control Trial study. This intended study is 
entailed on evaluating the efficacy of „Cold Chest Pack‟ in improving the pulmonary 
functions of patients with bronchial asthma via monitoring PEFR.  
4.2. ETHICAL CONSIDERATIONS 
4.2.1 ETHICAL CLEARANCE 
Ethical clearance was sought from the Institutional Ethics Committee prior to 
the start of the study and the approval for the same was granted.  
4.2.2 WRITTEN INFORMED CONSENT 
Subjects who fulfilled inclusion criteria were apprised about the purpose of the 
study and their rights as research subjects. Informed consent form was administered in 
English. 
As all the subjects understood spoke English, there was no requirement of 
translating the signed informed consent form into native language i.e., Tamil. 
Adequate time was given to each patient to go through the information sheet and their 
queries were answered. 
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Their right to withdraw anytime from the study and the need for willingness to 
participate voluntarily in the study was explained. All the subjects expressed their 
willingness to participate in the study by giving a signed informed consent. (A sample 
information sheet and consent form is enclosed as Annexure 1). 
 
Figure 4.1: Getting Informed Consent from the patient 
 
4.3 DURATION OF INTERVENTION AND STUDY PERIOD:  
 The entire duration of Intervention was carried out over a period of 5 
days/week for 5 weeks (Therefore a net total of 25 days) and the complete duration of 
study was observed for a total period of 10 months. 
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4.4 SAMPLE SIZE: 
 The study comprised a total of 71 study participants. The sample size is 
categorized under two groups. First group (n=37) represents intervention groups and 
the remaining 34 belongs under the control group.  
4.5 SELECTION CRITERIA:  
The following intervention study was carried out, by carrying out certain 
inclusion and exclusion criteria, which is given below. 
4.5.1. Inclusion Criteria:  
 Age : 20 to 44 years,  
 Gender: Both male and female subjects 
 Patients with history of asthma or other typical clinical symptoms associated 
with respiratory issues  
 Willingness to participate in the study.    
4.5.2. Exclusion Criteria:  
While selecting the study participants, there are certain factors that must be 
observed beforehand. These exclusion factors are: 
 Subjects who had participated in another clinical trial in the previous months 
 Have received systemic corticosteroids in the previous 2 weeks  
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 With systemic infection, respiratory infection, pulmonary tuberculosis and 
fungal infection in the previous 1 month. 
 Hospitalization due to acute exacerbation of asthma in the previous 3 months or 
in the baseline period  
 With other severe primary diseases including hypertension, cancer, 
hyperthyroidism, bronchiectasis, cardiac insufficiency and conditions. 
 
4.6 METHODOLOGY: 
The methodology involves two groups in this study. A total of 71 patients who 
were fulfilling inclusion criteria participated in the study. Prior to the retrieval of the 
informed consent, the PEFR was recorded with base-line measurement and 
randomizing under 2 groups as stated below with ‟37 individuals‟ in intervention 
group and the remaining 34 under the Control group.  
Intervention group were given Cold Chest pack for the duration of 30 minutes 
for 25 days (5 days/week for 5 weeks) along with conventional medicine. Control 
group will be only under conventional medicine. After 5 weeks, again PEFR was 
recorded for both groups. Assessments based on the pulmonary function before and 
after the intervention period determines the efficacy of cold chest pack in treating 
bronchial asthma. 
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Figure 4.2: Flowchart representation of Research Methodology 
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Out of 71 subjects, 7 subjects discontinued with the practice during different 
time of the study. All subjects are free to withdraw from participation in the study at 
any time, for any reason, specified or unspecified, and without prejudice to further 
treatment. Subjects who are withdrawn from the study were not being replaced. 
4.7 INTERVENTION PROCEDURE: 
Cold Chest back was performed among the study participants in the sessions with 
a total duration of 30 minutes. 
 Patients are made to be in sitting/supine position during the intervention. 
 The chest pack, comprised cotton cloth which is approximately 8-10 inches in 
width, 6-8 feet in length, should be loosely rolled up, dipped into water at 58
o
F 
- 62
o
F, and wrung out without unrolling.  
 The bandage is applied in a sort of “figure 8” fashion. ( bandage applied 
alternately to two parts, usually two segments of a limb above and below the 
joint, in such a way that the turns describe the figure 8) 
 A flannel bandage of the same width and a little greater length is applied over 
the moist bandage precisely the same manner to make it fit snugly at every 
point so as exclude the air.  
  The pack was removed after 30 min.  
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The below (figure) represents the different types of cold chest pack:  
 
Figure 4.3: Chest pack types (Square Chest Pack, Roller Chest Pack and 
Abdominal Bandage) 
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Figure 4.4: Illustrative representation of application of Cold Chest pack to 
patients in sitting position 
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Figure 4.5: Illustrative representation of application of Cold Chest pack to 
patients in lying position 
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4.8 ASSESSMENT OF PULMONARY FUNCTION VIA PEAK EXPIRATORY 
FLOW RATE (PEFR): 
4.8.1 Peak Expiratory Flow Rate: 
 The Peak Expiratory Flow Rate (PEFR) will be recorded using the Mini-
Wright peak flow meter (Airmed Clement Clarkes International, England) as 
per the standard method of B M Wright.  
 The subjects were instructed to take a maximal inspiration and blow into the 
mouth piece of the device rapidly and forcefully, while standing.  
 The values of PEFR achieved in 3 successive attempts were recorded and the 
highest of 3 values was taken for analysis.  
 
Figure 4.6: PEFR (Airmed Clement Clarkes International, England) 
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Figure 4.7: Representation of parts of PEF Meter  
 
 
Figure 4.8: Illustrative representation of using PEFR by patients 
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4.9. DATA COLLECTION METHODS: 
TOOLS: 
 All the parameters recorded by Mini-Wright peak flow meter at baseline and 5 
weeks after the cold chest pack intervention.  
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5.0 RESULTS 
The following chapter represents the overall results of the current study that 
determines the effectiveness of Cold Chest Pack among the intervention (CHPK) and 
Control group. The resultant outcomes from the interventional studies were monitored 
from assessing the pulmonary function test using PEFR test, which were further 
subjected to statistical analysis. 
5.1 STATISTICAL ANALYSIS 
 The following data for each subsets were expressed Mean± SEM. Parametric 
test had been used since the data fall on normal distribution (P>0.05). Comparison of 
Mean difference for inter group done using unpaired t test and intra group difference 
done using paired t test. P value set as P<0.05 significant. R statistical software 
version 3.1.1 was used for the statistical analysis and Graph pad version 5 used for the 
graphical representation. 
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The below table represents the anthropometric variables between groups:  
 
Table: 5.1 - Anthropometric variables between the groups 
VARIABLE CHPK GROUP CONTROL GROUP 
Height (cm) 160.4±23.90 158.8±21.29 
Weight (kg) 68.26±8.72 70.62±13.45 
BMI (kg/m
2
) 26.70±3.68 25.81±4.56 
Male/Female 12/20 10/22 
 
 
Table 1 shows the anthropometry parameters of participants. All the parameters like 
height (CHPK group: 160.4±23.90 cm; control group: 158.8±21.29 cm), weight 
(CHPK group: 68.26±8.72 kg; control group: 70.62±13.45) and BMI (CHPK group: 
26.70±3.68; control group: 25.81±4.56) were showed no significant difference in 
between the group and found normal in range. They are considered as healthy 
volunteers and were included for this study. 
 
 
 
 
62 
 
Overall Effect of Cold Chest Pack among the intervention and control groups 
The following table and illustration depicts the overall effect of pulmonary 
function via utilizing Cold chest pack among intervention and control groups 
 
Table. 5.2: Effect of Cold Chest Pack on PEFR in both CHPK group and control 
group 
Data expressed as Mean and SEM. Paired t test was done to compare the mean 
difference. P<0.05 set as significant. #comparison of after PEFR between CHPK and 
control group using unpaired t test. ##P<0.0001.  
 
Table 2 shows the effect of cold chest pack on pulmonary functioning via assessing 
the PEFR variables among both control and CHPK group. After CHPK intervention, 
PEFR showed significant (P<0.01) increase from 181.6±10.67 l/min to 266.7±13.82 
l/min in CHPK group. Whereas, no such significant changes were found in the control 
group subjects (186.9±10.67 /min to198.1±10.96 l/min). 
 
 
 
variable  CHPK p 
value  
Control  P value  
Before  After  Before  After  
PEFR 
(l/min) 
181.6±10.67 266.7±13.82 
##
 0.0001 186.9±10.67 198.1±10.96 0.4 
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Fig 5.1: Effect of Cold Chest Pack on PEFR in both CHPK group and control 
group 
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Figure 1 shows the effect of cold chest pack on pulmonary functioning via assessing 
the PEFR variables among both control and CHPK group. After CHPK intervention, 
PEFR showed significant (P<0.01) increase from 181.6±10.67 l/min to 266.7±13.82 
l/min in CHPK group. Whereas, no such significant changes were found in the control 
group subjects (186.9±10.67 /min to198.1±10.96 l/min). 
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Gender based investigation on the effect of cold chest pack via determining 
PEFR between CHPK and Control Group 
The following table and illustration depicts the gender based representation of 
pulmonary function via utilizing Cold chest pack among intervention and control 
groups.  
 
Table. 5.3: Effect of Cold Chest Pack on PEFR among the male subjects between 
CHPK group and control group 
Data expressed as Mean and SEM. Paired t test was done to compare the mean 
difference. P<0.05 set as significant. #comparison of after PEFR between CHPK and 
control group using unpaired t test. #P<0.001.  
 
Table 3 shows the effect of cold chest pack among male subjects on pulmonary 
functioning via assessing the PEFR variables among both control and CHPK group. 
After CHPK intervention, PEFR showed significant (P<0.01) increase from 
171.7±12.17 l/min to 285.4±10.80 l/min in CHPK group. Whereas, no such significant 
changes were found in the control group subjects (176.2±15.17 /min to 185.1±11.0 
l/min).   
 
variable  CHPK p 
value  
Control  P value  
Before  After  Before  After  
PEFR 
(l/min) 
171.7±12.17 285.4±10.80
#
 0.001 176.2±15.17 185.1±11.0 0.7 
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Figure 5.2: Effect of Cold Chest Pack on PEFR among the male subjects 
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Figure 2 shows the effect of cold chest pack among male subjects on pulmonary 
functioning via assessing the PEFR variables among both control and CHPK group. 
After CHPK intervention, PEFR showed significant (P<0.01) increase from 
171.7±12.17 l/min to 285.4±10.80 l/min in CHPK group. Whereas, no such significant 
changes were found in the control group subjects (176.2±15.17 /min to 185.1±11.0 
l/min).   
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Table.5.4: Effect of Cold Chest Pack on PEFR among the female subjects 
between CHPK group and control group 
Data expressed as Mean and SEM. Paired t test was done to compare the mean 
difference. P<0.05 set as significant. #comparison of after PEFR between CHPK and 
control group using unpaired t test. #P<0.001. 
 
 
Table 4 shows the effect of cold chest pack among female subjects on pulmonary 
functioning via assessing the PEFR variables among both control and CHPK group. 
After CHPK intervention, PEFR showed significant (P<0.01) increase from 
178.7±15.24 l/min to 265.92±17.10 l/min in CHPK group. Whereas, no such 
significant changes were found in the control group subjects (186.45±12.07 /min 
to195.77±14.09 l/min). 
 
 
 
variable  CHPK p 
value  
Control  P value  
Before  After  Before  After  
PEFR 
(l/min) 
178.7±15.24 265.92±17.10
#
 0.001 186.45±12.07 195.77±14.09 0.8 
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Figure 5.3: Effect of Cold Chest Pack on PEFR among the female subjects 
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Figure 3 shows the effect of cold chest pack among female subjects on pulmonary 
functioning via assessing the PEFR variables among both control and CHPK group. 
After CHPK intervention, PEFR showed significant (P<0.01) increase from 
178.7±15.24 l/min to 265.92±17.10 l/min in CHPK group. Whereas, no such 
significant changes were found in the control group subjects (186.45±12.07 /min 
to195.77±14.09 l/min). 
 
 
68 
 
6.0 DISCUSSIONS 
The present study showed that the incorporation of Cold Chest Pack, was 
carried out over a period of 5 days/week for 5 weeks (net total of 25 days) and the 
complete duration of study was observed for 10 months. The intervention appeared to 
have significant impact in the overall PEFR ranges in Pulmonary Function. PEFR acts 
as major tool for assessing the influence of pulmonary function.  Autonomic 
disturbances could have an adverse impact on pulmonary function.
 
Bronchial asthma is regarded as the dangerous threat, causing an increase in the 
mortality, of all age groups. There has been a growing concern with regards to PEFR, 
which needs necessary interventional approach which is efficacious and impactful on 
a longer term. Under such situations, many countries rely on naturopathic approaches 
for treating systemic disorders
83
. 
 
The abnormalities observed/monitored in the PEFR and pulmonary functioning 
directly reflects Bronchial asthma and other associated problems. During its maximal 
expiratory effort from total lung capacity, the peak expiratory flow occurs in the first 
200 milliseconds, which is in the effort dependent portion of expiration. PEF is 
affected by the fullness of the preceding inspiration, caliber of the large airways, 
expiratory muscle strength, and voluntary effort. As might be expected, PEF can vary 
substantially with patient effort and coordination
84
. 
Peak Expiratory Flow Rate (PEFR) is an important parameter in the 
management of bronchial asthma. Measurement of PEFR in bronchial asthma is 
similar to measurement of blood pressure in managing hypertension and measurement 
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of blood glucose in managing diabetes mellitus. Peak expiratory flow provided a 
simple quantitative and reproducible measure of resistance and severity of airflow 
obstruction. Peak expiratory flow can be measured with inexpensive and portable peak 
expiratory flow meter. Peak flow monitoring can be used for short term monitoring, 
managing exacerbations and daily long term monitoring
85
.  
With the application of cold chest pack has been used as treatment for choice in 
treating the flow rate and also aids in reducing the overall weekly attacks when on 
combination with following yoga for weeks as well
74
.  
Another study evaluated the effects of a cold chest pack in isolation on 
pulmonary functions in bronchial asthma patients, and the studies conducted in 
evaluating immediate effect of a cold chest pack on the Peak Expiratory Flow Rate 
(PEFR) and whether the immediate effect would change after treatment with other 
natural remedies and yogic practices in bronchial asthma patients
5
. 
These abnormalities and growing illness could be majorly attributed to an 
individual‟s poor lifestyle habits, physical stress. However these factors are hopefully 
modifiable. Utilizing naturopathic standards as an effective approach on long term 
treatment could assist in a strong and healthy systemic circulation. 
The usage of Cold Chest Pack, which is a part of hydrotherapy mediated 
interventional approach, has been in practice for many centuries. Through 
incorporation of hydrotherapy mediated with Cold Chest Pack could facilitate in 
improving the pulmonary functioning, quite effectively. Since there is not enough 
literature studies have focused on Cold Chest Pack and its impact on. The current 
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study performed a randomized control study design among 32 Bronchial Asthmatic 
patients as control and 32 Bronchial Asthmatic Patients as intervention group over a 
period of 10 months.  
As the chest pack has been used as treatment choice in the treatment of 
bronchial asthma followed by naturopathic treatments in numerous naturopathy 
hospitals as they are crucial for carrying out investigations on understanding the 
control group, as it is not possible for ascribing the improved PEFR intractable 
asthma.    
From the observed studies, the PEFR was measured before and after the 
intervention study for comparative analysis on the overall changes in the PEFR. From 
the results, the research inferred that with incorporating Cold Chest Pack mediated 
interventional approach, has drastically improved the PEFR ranges, in both the groups 
as the Pre interventional assessment with regards as the expiratory flow of the lungs is 
greater as the bronchial openings were freed/ broadened with incorporating Cold 
Chest Pack approach.  
The interventional approach involving Cold Chest Pack over the period of 10 
months has drastically improved the pulmonary Function which is observed on the 
basis of PEFR. PEFR represents maximum flow rate generated during a forceful 
exhalation, starting from full lung inflation.
  
PEFR primarily reflects large airway flow 
and depends on the voluntary effort and muscular strength of the patient.  
In our study, there was a demonstrable improvement in the pulmonary 
function. Through incorporating Cold Chest Pack, among study participant had a 
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noticeable benefit on general health status of the individual and thus promoting 
positive health. These beneficial effects were observed within the stipulated duration, 
exhibiting that the practice of naturopathic treatment over other treatment modes 
could have a lasting impact, since it rectifies the systemic irregularities, rather than 
targeting only on the particular illness
5
. 
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7.0 CONCLUSION 
The present study confirms that, by incorporating naturopathic treatment 
involving Cold Chest pack was effective in improving Bronchial asthma and 
improving the pulmonary functions via monitoring the expiratory flow rate, there by 
directly improving the sympatho-vagal balance among the study participants. Cold 
Chest Pack is a simplified procedure and is one of the effective treatments among 
hydrotherapic treatment, with no side effect in its treatment. From the study, the 
participants were only administered with Cold Chest pack treatment alone. Within the 
stipulated time interval, Pulmonary function was observed via monitoring the peak 
expiratory flow rate (PEFR) was significantly improved among the individuals.  
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LIMITATIONS:  
 The current study was a pilot study comprising only of minimal number of 
subjects.  
  The literature sources were limited regarding the therapeutic benefits of Cold 
Chest Pack. 
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RECOMMENDATIONS:  
The same study can be conducted on a larger population with suitable study 
design and some objective kind of outcome variables could be included to validate the 
current results.  
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8.0 SUMMARY 
 The study‟s objective was to determine the efficacy of incorporating Cold 
Chest Pack, in improving the peak expiratory flow rate for patients suffering 
from bronchial asthma. Peak expiratory flow rate (PEFR) as a result of forced 
expiration, represents an equivalent over spot measurement retrieved from 
slope from expiratory spirogram on steepest point. As PEFR relies as much on 
elastic recoil from lungs and also the caliber of peripheral airways.  
 The underlying abnormalities in these parameters in the pulmonary function is 
quite common and profound among bronchial asthmatic individuals, and also 
could have a deleterious impact and its related issues.  
 The following study was intended majorly towards determining the impact of 
Cold chest pack in improving the pulmonary functions via PEFR levels. The 
study was conducted among the bronchial asthmatics and patients who are 
susceptible as well as exhibit symptoms that attribute to bronchial asthma, over 
a total period of 10 months. The baseline measurements were monitored 
initially for evaluating the actual difference in the pulmonary functions via 
assessing the PEFR ranges.  From the observed study, the participants who 
were administered with hydrotherapic mediated intervention via cold chest 
pack, exhibited significant improvement in their overall PEFR readings.  
 The overall (Mean±SEM) showed significant improvement in the PEFR by the 
effect of cold chest pack on pulmonary functioning via assessing the PEFR 
variables among both control and CHPK group. After CHPK intervention, 
PEFR showed significant (P<0.01) increase from 181.6±10.67 l/min to 
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266.7±13.82 l/min in CHPK group. Whereas, no such significant changes were 
found in the control group subjects (186.9±10.67 l/min to198.1±10.96 l/min).  
 Also the overall (Mean±SEM) showed significant improvement in the PEFR by 
the effect of cold chest pack among male subjects on pulmonary functioning 
via assessing the PEFR variables among both control and CHPK group. After 
CHPK intervention, PEFR showed significant (P<0.01) increase from 
171.7±12.17 l/min to 285.4±10.80 l/min in CHPK group. Whereas, no such 
significant changes were found in the control group subjects (176.2±15.17 
l/min to 185.1±11.0 l/min).    
 The overall (Mean±SEM) showed significant improvement in the PEFR by the 
effect of cold chest pack among female subjects on pulmonary functioning via 
assessing the PEFR variables among both control and CHPK group. After 
CHPK intervention, PEFR showed significant (P<0.01) increase from 
178.7±15.24 l/min to 265.92±17.10 l/min in CHPK group. Whereas, no such 
significant changes were found in the control group subjects (186.45±12.07 
l/min to195.77±14.09 l/min). 
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9.0 ANNEXURE 
INFORMATION SHEET 
We are conducting a study on Bronchial Asthma among patients attending 
Government Yoga and Naturopathy Medical College Hospital, Chennai and for that 
your participation may be valuable to us. 
The purpose of the study is to evaluate the changes in pulmonary function through 
Cold Chest pack. 
The privacy of the patients in the research will be maintained throughout the study. In 
the event of any publication or presentation resulting from the research, no personally 
identifiable information will be shared. 
Taking part in this study is voluntary. You are free to decide whether to participate in 
this study or to withdraw at any time; your decision will not result in any loss of 
benefits to which you are otherwise entitled. 
The results of the special study may be intimated to you at the end of the study period. 
 
Signature of investigator:                                               Signature of participant: 
Date: 
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INFORMED CONSENT FORM 
Title of the study: Effects of Cold Chest Pack on Pulmonary functions of Patients 
with Bronchial Asthma 
Name of the Participant:  
Name of the Principal Investigator: Dr. R. Arthi 
Name of the Institution: Government Yoga & Naturopathy Medical College,  
Chennai – 600 106 
 
Documentation of the informed consent 
I _____________________________ have read the information in this form (or it has 
been read to me). I was free to ask any questions and they have been answered. I am 
over 18 years of age and, exercising my free power of choice, hereby give my consent 
to be included as a participant in “Effect of Cold Chest Pack on Pulmonary functions 
of Patients with Bronchial Asthma” 
1. I have read and understood this consent form and the information provided to me. 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by the investigator. 
5. I have been informed the investigator of all the treatments I am taking or have taken 
in the past ________ months including any native (alternative) treatment. 
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6. I have been advised about the risks associated with my participation in this study. 
7. I agree to cooperate with the investigator and I will inform him/her immediately if I 
suffer unusual symptoms.  
8. I have not participated in any research study within the past _________month(s).  
9. I am aware of the fact that I can opt out of the study at any time without having to 
give any reason and this will not affect my future treatment in this hospital.  
10. I am also aware that the investigator may terminate my participation in the study at 
any time, for any reason, without my consent.  
11. I hereby give permission to the investigators to release the information obtained 
from me as result of participation in this study to the sponsors, regulatory authorities, 
Govt. agencies, and IEC. I understand that they are publicly presented. 
12. I have understood that my identity will be kept confidential if my data are publicly 
presented. 
13. I have had my questions answered to my satisfaction. 
14. I have decided to be in the research study. 
 
I am aware that if I have any question during this study, I should contact the 
investigator. By signing this consent form, I attest that the information given in this 
document has been clearly explained to me and understood by me, I will be given a 
copy of this consent document. 
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For adult participants: 
Name and signature / thumb impression of the participant (or legal 
representative if participant incompetent) 
Name _________________________ Signature_________________  
Date________________ 
Name and Signature of impartial witness (required for illiterate patients): 
Name _________________________ Signature_________________  
Date________________ 
Address and contact number of the impartial witness: 
Name and Signature of the investigator or his representative obtaining consent: 
Name ___________________          Signature_________________  
Date________________ 
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INFORMATION TO PARTICIPANTS 
Investigator: Dr. R. Arthi 
Name of Participant: 
Title: Effect of Cold Chest Pack on Pulmonary functions of Patients with 
Bronchial Asthma 
You are invited to take part in this research/ study /procedures. The information in this 
document is meant to help you decide whether or not to take part. Please feel free to 
ask if you have any queries or concerns. You are being asked to participate in this 
study being conducted in Government Yoga & Naturopathy Medical College, Chennai 
– 600 106 
What is the Purpose of the Research? 
The purpose of the study to evaluate the effect of Cold Chest pack on pulmonary 
changes in patients with Bronchial asthma. 
The Study Design 
Randomized controlled Trial  
Study Procedures 
The chest pack, consisted of a cotton cloth, approximately 8-10 inches in width, 6-8 
feet in length, should be loosely rolled up, dipped into water at 58
o
F - 62
o
F, and wrung 
out without unrolling. The bandage is applied in a sort of “figure 8” fashion. A flannel 
bandage of the same width and a little greater length is applied over the moist bandage 
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precisely the same manner to make it fit snugly at every point so as exclude the air. 
The pack was removed after 30 min. Patients are made to be in supine position during 
the intervention. 
Possible Risks to you - Nil 
Possible benefits to you – Improvement in lung volume and capacity 
Possible benefits to other people 
The result of the research may provide benefits to the society in terms of 
improving the treatment efficacy for bronchial asthma patients.  
Confidentiality of the information obtained from you 
You have the right to confidentiality regarding the privacy of your medical 
information (personal details, results of physical examinations, investigations, and 
your medical history). By signing this document, you will be allowing the research 
team investigators, other study personnel, sponsors, IEC and any person or agency 
required by law like the Drug Controller General of India to view your data, if 
required. 
The information from this study, if published in scientific journals or presented at 
scientific meetings, will not reveal your identity. 
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How will your decision to not participate in the study affect you? 
Your decisions to not to participate in this research study will not affect your medical 
care or your relationship with investigator or the institution. Your doctor will still take 
care of you and you will not lose any benefits to which you are entitled. 
 
Can you decide to stop participating in the study once you start? 
The participation in this research is purely voluntary and you have the right to 
withdraw from this study at any time during course of the study without giving any 
reasons. 
However, it is advisable that you talk to the research team prior to stopping the 
treatment 
 
 
 
